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Summary
G-protein signaling pathways, as key components of physiologic responsiveness and timing, are
frequent targets for pharmacologic intervention. Here, we identify an effector for heterotrimeric G-
protein α subunit (EhGα1) signaling from Entamoeba histolytica, the causative agent of amoebic
colitis. EhGα1 interacts with this effector and GTPase-accelerating protein (GAP), EhRGS-
RhoGEF, in a nucleotide state-selective fashion. Co-expression of EhRGS-RhoGEF with
constitutively active EhGα1 and EhRacC leads to Rac-dependent spreading in Drosophila S2
cells. EhRGS-RhoGEF overexpression in E. histolytica trophozoites leads to reduced migration
toward serum and lower cysteine protease activity, as well as reduced attachment to, and killing
of, host cells. A 2.3 Å crystal structure of the full-length EhRGS-RhoGEF reveals a putative
inhibitory helix engaging the DH domain Rho-binding surface and the PH domain. Mutational
analysis of the EhGα1/EhRGS-RhoGEF interface confirms a canonical RGS domain rather than a
RhoGEF-RGS (“rgRGS”) domain, suggesting a convergent evolution toward heterotrimeric and
small G-protein cross-talk.
Introduction
Heterotrimeric G-protein signaling pathways are frequent targets for pharmacologic
manipulation (Gilchrist, 2007). The Gα subunit in its inactive, GDP-bound conformation
engages the obligate Gβγ dimer (Oldham and Hamm, 2008). A ligand-activated seven-
transmembrane G-protein coupled receptor (GPCR) promotes nucleotide exchange on the
Gα subunit. Upon binding of GTP by the Gα subunit, three switch regions undergo a
conformational change, leading to separation from Gβγ and subsequent activation of
downstream effectors such as adenylyl cyclases, phospholipase C, and Rho-family guanine
nucleotide exchange factors (RhoGEFs) (Aittaleb et al., 2010; Oldham and Hamm, 2008).
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Signaling is terminated by the GTPase activity of the Gα subunit and reassembly of the
Gα·GDP/Gβγ heterotrimer.
“Regulator of G-protein signaling’ (RGS) proteins accelerate the intrinsic GTP hydrolysis
activity of Gα subunits and thereby serve as negative regulators of signaling (Kimple et al.,
2011). Canonical nine-helix RGS domains exhibit highest affinity for Gα in its transition-
state mimetic form, stabilizing the switch regions for efficient hydrolysis (Tesmer et al.,
1997). Members of the RGS-RhoGEF family of Gα effectors contain N-termini with
similarity to RGS domains (called ‘RhoGEF-RGS’ or ‘rgRGS’ domains), in combination
with Dbl homology (DH) and pleckstrin homology (PH) domains that together mediate
activation of Rho family GTPases (Aittaleb et al., 2010). The DH domain engages substrate
Rho GTPases, promoting nucleotide release, while the PH domain frequently modulates
exchange in various Dbl-family RhoGEF members (Rossman and Sondek, 2005). In contrast
to 9-helix RGS domains, rgRGS domains have a distinct 12-helix fold and engage Gα12/13
subunits through an effector-like interface involving primarily switch 2 and the α3 helix
(Aittaleb et al., 2010). An N-terminal extension of the rgRGS domain containing an “IIG”
sequence motif contacts the Gα12/13 switch regions and all-helical domain and, in the case
of p115 RhoGEF, is required for GTPase accelerating protein (GAP) activity toward
Gα12/13 subunits. Although structures of RGS-RhoGEFs with both the rgRGS and DH-PH
domain tandems have not yet been elucidated, p115 RhoGEF is thought to be activated by
an allosteric “GEF switch” mechanism that involves a conformational change of an N-
terminal extension of the DH domain (Chen et al., 2011). Recent low-resolution structural
studies of full-length p115 RhoGEF suggest an elongated domain architecture and a
potential bimodal interaction with Gα13, namely the effector interface with the rgRGS
domain and a potential additional interface with the DH domain (Chen et al., 2012). The
activation mechanism of another mammalian RGS-RhoGEF, PDZ-RhoGEF, is thought to be
complex, involving disruption of an electrostatic RGS-DH linker and DH domain
interaction, perturbation of a putative RGS-DH linker “molten globule”, and membrane
recruitment, as well as a “GEF switch” (Bielnicki et al., 2011; Zheng et al., 2009). Low-
resolution SAXS studies of PDZ-RhoGEF also suggested an ensemble of elongated domain
architectures (Bielnicki et al., 2011).
Entamoeba histolytica causes an estimated 50 million infections and 100,000 deaths per year
worldwide, with highest incidence in countries with poor barriers between drinking water
and sewage (WHO, 1997). Following ingestion of encysted E. histolytica, the trophozoite, or
amoeboid form of the parasite attaches to and destroys intestinal epithelial cells, giving rise
to amoebic colitis (Ralston and Petri, 2011). Although the molecular details of signaling
pathways in E. histolytica remain understudied, a relatively large family of Rho GTPases
and Dbl family RhoGEFs are known to modulate cytoskeletal dynamics, as well as key
pathogenic processes such as trophozoite migration, extracellular matrix invasion, and
killing and phagocytosis of host cells (Bosch et al., 2011; Guillen, 1996; Meza et al., 2006).
Recently, we identified a functional heterotrimeric G-protein signaling pathway in E.
histolytica; perturbation of the Gα subunit, EhGα1, elucidated positive regulatory roles for
G-protein signaling in pathogenic processes such as trophozoite migration and invasion, host
cell attachment, and cell killing (manuscript in press). Overexpression of either wild type
EhGα1 or a dominant negative mutant in E. histolytica trophozoites resulted in altered
transcription of numerous genes that have implicated multiple potential mechanisms by
which G-protein signaling modulates pathogenesis. From this study, a set of Rho GTPase
signaling proteins, including an RGS-RhoGEF, and actin-associated proteins was observed
to be differentially transcribed downstream of heterotrimeric G-proteins (Table S1). We
hypothesized that EhRGS-RhoGEF, like its mammalian homologs, serves as an EhGα1
effector and signals through Rho family GTPases, with important roles in Entamoeba
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histolytica pathogenesis. Here, our results describe EhRGS-RhoGEF as an effector and
GTPase accelerating protein (GAP) of EhGα1, with importance for E. histolytica motility,
host cell attachment, cell killing, and cysteine protease secretion. Activation of EhRGS-
RhoGEF by co-expression of constitutively active EhGα1 and EhRacC leads to Rac family
GTPase-dependent cell spreading in Drosophila S2 cells. Furthermore, we provide a crystal
structure of the full-length RGS-RhoGEF in the inactive state, elucidating its molecular
architecture and likely distinct evolutionary origin relative to the mammalian RGS-
RhoGEFs.
Results
EhGα1 engages an RGS-RhoGEF effector and GTPase accelerating protein
The E. histolytica genome encodes a single classical Gα subunit effector, an RGS domain-
containing RhoGEF (GenBank XP_653063; named EhRGS-RhoGEF) with distant similarity
to the RGS-RhoGEF effectors of mammalian Gα12/13 subunits (Fig. S1). Transcription of
EhRGS-RhoGEF was seen to be up-regulated upon overexpression of EhGα1 in E.
histolytica trophozoites, suggesting a functional link to heterotrimeric G-protein signaling
(Table S1). EhRGS-RhoGEF was purified from E. coli (Fig. S2) and found to bind directly
to EhGα1 selectively in its GDP·AlF4− (AMF) nucleotide state as measured by surface
plasmon resonance (Fig. 1 A-D). Reciprocal immobilization experiments each indicated an
~5 μM EhGα1·AMF/EhRGS-RhoGEF dissociation constant (KD). EhRGS-RhoGEF also
interacted with the constitutively active, GTPase deficient EhGα1(Q189L) mutant in its
GTP-bound form, although with ~20-fold lower affinity than for EhGα1·AMF (KD ≈ 110
μM) (Fig. 1B). The EhGα1(Q189L)·GTP/EhRGS-RhoGEF binding affinity could not be
precisely determined by equilibrium binding analysis due to concentration limitations of our
assay. The preference of EhRGS-RhoGEF for the AMF nucleotide state over the GTP-
bound state of EhGα1 is consistent with a similar order-of-magnitude difference in p115
RhoGEF affinity for Gαi1/13·AMF compared to Gαi1/13·GTPγS (Chen et al., 2005). To
determine whether the interaction occurs through the RGS domain of EhRGS-RhoGEF, a
conserved glutamate at the predicted Gα subunit-binding surface was mutated to lysine
(E39K; Fig. S1). Despite proper global folding of the E39K mutant (Fig. S2B), it exhibited
drastically reduced affinity for EhGα1·AMF (Fig. 1D). The isolated RGS domain of
EhRGS-RhoGEF could not be produced from E. coli. However, RGS domain expressed in
HEK 293T cells was seen to specifically co-precipitate with purified EhGα1·AMF and
EhGα1(Q189L)·GTP, but not EhGα1·GDP (Fig. S2C), suggesting that the RGS domain
alone is sufficient to bind EhGα1.
The relatively high affinity of wild type EhRGS-RhoGEF for the hydrolysis transition state-
mimetic (AMF) form of EhGα1 suggested that the RGS domain of EhRGS-RhoGEF may
serve as a GTPase accelerating protein (GAP) for EhGα1. Interestingly, EhRGS-RhoGEF
lacks the N-terminal extension containing the IIG motif that is required for the GAP activity
of p115 RhoGEF (Fig. S1) (Aittaleb et al., 2010). However, single turnover GTP hydrolysis
assays demonstrated that wild type EhRGS-RhoGEF, but not the EhRGS-RhoGEF(E39K)
mutant, accelerates the intrinsic GTP hydrolysis activity of EhGα1 in a concentration-
dependent fashion (Fig. 1E). Mutation of the conserved Asn-83 in the EhRGS-RhoGEF
RGS domain, predicted to contact and orient EhGα1 switch residues for efficient catalysis
of GTP hydrolysis (Tesmer et al., 1997), also eliminated GAP activity (Fig. 1F) and
dramatically reduced EhRGS-RhoGEF/EhGα1 binding affinity (Fig. 1C).
EhGα1 and EhRacC activate EhRGS-RhoGEF to promote Rho-dependent cell spreading
To determine the ability of EhRGS-RhoGEF to modulate Rho-dependent cellular processes
and its potential regulation by EhGα1, we utilized Drosophila S2 cells that undergo a
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dramatic morphological transition with distinctive reorganization of actin structures when
Rho family GTPases are activated by various stimuli (Rogers et al., 2003). For example,
overexpression of a GTPase-deficient and constitutively active D.m. Rac1(G14V) lead to
cell spreading in ~80% of S2 cells on a poly-lysine coated surface, as compared to ~20% of
cells expressing RFP (Figure 2A,B). Expression of constitutively active EhGα1(Q189L) and
EhRGS-RhoGEF was not sufficient to significantly increase cell spreading. However,
additional expression of constitutively active EhRacC(Q65L) lead to spreading, suggesting
that GTP-bound EhGα1 and EhRacC are necessary to activate EhRGS-RhoGEF.
Importantly, EhRacC(Q65L) alone (not shown) or in combination with EhGα1 (Figure 2)
did not trigger S2 cell spreading, indicating its inability to productively engage the
endogenous D.m. Rho GTPase signaling machinery independently of EhRGS-RhoGEF.
Wild type EhGα1 did not activate EhRGS-RhoGEF, and the EhRGS-RhoGEF(E39K)
mutation prevented an increase cell spreading (Fig. 2A,B). Thus, co-expression of EhRGS-
RhoGEF with constitutively active EhRacC and interaction with constitutively active
EhGα1 at the RGS domain are required for enhanced cell spreading.
The observed cell spreading phenotype strongly suggested that EhRGS-RhoGEF was
signaling through endogenous Drosophila Rho family GTPases. To investigate the
dependence of the observed phenotype on endogenous Rho family GTPases, we knocked
down expression of D.m. Rac1/2 (both isoforms targeted), Rho, and mtl by RNA
interference, as demonstrated previously in S2 cells (Rogers and Rogers, 2008). Specific
knock down of D.m. Rac GTPases abolished the cell spreading effect of EhRGS-RhoGEF,
EhGα1(Q189L), and EhRacC(Q65L), suggesting that either or both D.m. Rac isoforms may
serve as substrates for overexpressed EhRGS-RhoGEF (Figure 2A).
To test whether activated EhRacC directly engages EhRGS-RhoGEF, surface plasmon
resonance was utilized. EhRGS-RhoGEF selectively bound EhRacC(Q65L)·GTP, to the
exclusion of EhRacC·GDP or nucleotide-free EhRacC (Figure 4D). This pattern of
nucleotide state selectivity was consistent with a Rho GTPase and effector-like interaction,
rather than a RhoGEF and substrate Rho GTPase relationship. Although the observed
recombinant EhRacC(Q65L)/EhRGS-RhoGEF affinity was relatively low (KD ≈ 34 ± 9
μM), the cell-spreading experiments suggest that a productive interaction occurs in a
cellular context. The interaction of EhRGS-RhoGEF with an active species of Rho family
GTPase was reminiscent of the structurally elucidated interaction between human
RhoA·GTPγS and a hydrophobic patch on the PH domain of PDZ-RhoGEF (Chen et al.,
2010b). An analysis of the PDZ-RhoGEF PH domain residues involved in activated RhoA
binding (PDB id 3KZ1) revealed poor conservation with the corresponding PH domain
residues of EhRGS-RhoGEF (19% identity, 25% similarity); thus, we do not predict that
EhRacC·GTP binds EhRGS-RhoGEF in a similar fashion. However, a direct interaction
does occur between activated EhRacC and EhRGS-RhoGEF, potentially explaining the
required co-expression of EhRacC(Q65L), together with EhGα1(Q189L) and EhRGS-
RhoGEF to enhance cell spreading (Figure 2A,B).
EhRGS-RhoGEF modulates pathogenic processes of E. histolytica trophozoites
We next investigated the role(s) of RGS-RhoGEF signaling in E. histolytica trophozoites by
engineering the virulent HM-1:IMSS strain to stably overexpress wild type EhRGS-
RhoGEF (Fig. 3). We focused on measuring the effect of EhRGS-RhoGEF overexpression
on trophozoite chemotactic migration, host cell attachment, and cell killing, given the known
dependence of these vital pathogenic processes on actin cytoskeletal dynamics, as well as
Rho GTPases and Dbl family RhoGEFs (Guillen, 1996; Meza et al., 2006). Trophozoites
ectopically overexpressing EhRGS-RhoGEF killed host cells less efficiently than the parent
strain, as indicated by a membrane integrity assay (Fig. 3A). A number of cytotoxic proteins
are involved in host cell killing, including membrane-perforating amoebapores and cysteine
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proteases (Ralston and Petri, 2011). Reduced secretion of active cysteine proteases, as
measured by an azo-collagen assay (Fig. 3B), may account in part for the impaired cell
killing of the EhRGS-RhoGEF-expressing trophzoite strain. Direct attachment of E.
histolytica trophozoites to host epithelial cells, primarily through a galactose-inhibitable
lectin (Petri et al., 2002), is also required for tissue destruction. Amoebae overexpressing
EhRGS-RhoGEF showed reduced attachment to Chinese Hamster Ovary (CHO) cell
monolayers compared to the parent strain (Fig. 3D). E. histolytica trophozoites are also
highly motile, a feature that is dependent on a dynamic actin cytoskeleton regulated by Rho
family GTPase signaling (Meza et al., 2006). Transwell migration experiments indicated
that overexpression of EhRGS-RhoGEF also decreases trophozoite chemotactic migration
toward serum, but not random migration (Figure 3C), suggesting that interfering with the
EhGα1/EhRGS-RhoGEF signaling axis modulates the E. histolytica migratory response to
serum factors.
A crystal structure of EhRGS-RhoGEF
While isolated domains from mammalian RGS-RhoGEFs have been structurally
characterized (Aittaleb et al., 2010), a high-resolution structure of an RGS domain together
with a DH-PH domain tandem has not been elucidated to date. We obtained a crystal
structure of a nearly full-length EhRGS-RhoGEF protein (lacking only two residues from
each terminus) to 2.3 Å by single wavelength anomalous dispersion (SAD) (Table 1). The
structural model exhibits an N-terminal, canonical nine-helix RGS domain, an oblong DH
domain, and a C-terminal PH domain (Figs. 4A). The RGS domain interacts with the DH
domain surface opposite from the PH domain and the putative Rho GTPase binding site
(Fig. 4). The linker between the RGS and DH domains wraps around the oblong helical
bundle of the DH domain (Fig. 4A), forming an additional helix (termed the ‘inhibitory
helix’).
The RGS domain of EhRGS-RhoGEF is involved in multiple crystal contacts (Fig. S5);
specifically, the putative Gα-binding surfaces of neighboring EhRGS-RhoGEF molecules in
the crystal lattice contact one another. Although crystal contacts may modestly affect the
disposition of the RGS domain, the similarity of its conformation to mammalian RGS
domains in both crystallographic and NMR studies (Fig. 6B)(Soundararajan et al., 2008),
and significant burial of hydrophobic surface area (~850 Å2) at the RGS-DH domain
interface suggest that the crystal structure architecture accurately reflects that of EhRGS-
RhoGEF in solution.
The PH domain exhibits a conserved overall fold despite weak sequence similarity (2.9 Å
r.m.s.d. compared to 324 equivalent residues of the Dbs PH domain with only 51% sequence
similarity) (Fig. S3A). An analysis of protein sequence motifs and comparison of the
EhRGS-RhoGEF PH domain structure to other PH domains in complex with phospholipid
head groups (Ferguson et al., 2000) revealed poor conservation of a potential phospholipid-
binding site on EhRGS-RhoGEF. Thus, we do not hypothesize that the EhRGS-RhoGEF PH
domain directly associates with phospholipids.
The EhRGS-RhoGEF DH domain is most similar to that of Intersectin (Dali server Z-score
19.4; PDB id 1KI1). Superposition of Intersectin/Cdc42 (Snyder et al., 2002) and EhRGS-
RhoGEF highlights a number of DH domain structural differences (Fig. 4B). The α6 helix
of EhRGS-RhoGEF, which is the longest of the Intersectin DH domain, is disrupted by a
loop, giving rise to two helices at ~90° relative orientations (termed α6a and α6b). The PH
domain adopts a very different orientation relative to the DH domain in EhRGS-RhoGEF as
compared to Intersectin (Fig. 4B). The PH domain of RGS-RhoGEF directly obstructs the
putative Rho binding site, similar to a number of mammalian RhoGEFs, e.g. Vav and Sos
(Das et al., 2000). The DH and PH domains of EhRGS-RhoGEF share a substantial interface
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(~1200 Å2 buried surface area) that occurs predominantly through hydrophobic interactions
between the α7 helix of the PH domain and the α3d, α4, α5, and α6b helices of the DH
domain (Figure S3B). Particularly, the hydrophobic side chains of Phe-393 and Met-397
project into an approximately triangular concavity formed by helices α3d, α4, and α5
(Figure S3B). The nature of the DH/PH domain interface suggests that the structural
relationship between the two domains observed in the crystal structure likely also exists in
solution. However, additional contacts of each domain with the inhibitory helix may also be
necessary to maintain the observed DH and PH domain relationship (Figure 5), and
alternative conformations are also possible.
The inhibitory helix coordinates occlusion of the Rho GTPase binding site
In the inactive state of EhRGS-RhoGEF, the inhibitory helix, the α6b helix of the DH
domain, and the PH domain all obstruct the presumptive Rho GTPase interaction surface of
the DH domain (Fig. 4), as predicted based on comparison with the Intersectin/Cdc42
structure (Snyder et al., 2002). In fact, the entire RGS-DH domain linker inhibitory helix lies
within the space occupied by the Rho GTPase substrate in numerous, well-conserved Dbl
family GEF/Rho interactions (Rossman and Sondek, 2005). The inhibitory helix interacts
with both the DH and PH domains through a series of hydrophobic and polar interactions
(Fig. 5, S4). The hydrophobic residues Leu-164, Ile-167, Ile-168, and Trp-175 interface with
a hydrophobic patch at the DH α6B helix/PH domain interface, consisting primarily of the
hydrophobic portion of Lys-386, Leu-387, Ile-406, and Ile-450 (Fig. 5, S4). Surrounding the
hydrophobic patch are a number of apparent polar and ionic interactions, including those
between Lys-161 of the inhibitory helix and Glu-511 of the PH domain as well as Lys-172
and Asp-383 of the inhibitory and DH domain α6B helices, respectively. The inhibitory
helix residues Lys-166 and Ile-170 also form limited contacts with a DH domain loop from a
neighboring molecule in the crystal lattice (Figure S5C), but these contacts likely do not
contribute to the observed main chain conformation. Notably, the RGS-DH linker containing
the putative inhibitory helix is much shorter in EhRGS-RhoGEF (26 residues) than the
corresponding linker in its mammalian homologs, with p115 RhoGEF possessing the next
shortest linker at 164 residues (Fig. S1C). Thus, it is likely that this region exhibits different
structural features and potentially performs different functions in mammalian RGS-
RhoGEFs.
Convergent evolution of the EhGα1/EhRGS-RhoGEF interface
The RGS/DH domain interface consists of a central hydrophobic region with peripheral
hydrogen bond and ionic interactions (Fig. 6A, S4B). The residues corresponding to this
domain interface are not highly conserved among mammalian RGS-RhoGEFs, such as p115
RhoGEF (Fig. S1). This observation, together with a previous small-angle X-ray scattering
(SAXS) analysis of the elongated p115 RhoGEF (Chen et al., 2012), suggests that the
structural relationships among the EhRGS-RhoGEF domains differ from those of
mammalian homologs.
The RGS domain of EhRGS-RhoGEF closely resembles the nine-helix bundle found in
canonical RGS domains, such as RGS4 (Fig. 6B). This canonical RGS domain fold is
distinct from the 12-helix rgRGS domains of mammalian RGS-RhoGEFs, such as p115
(Fig. 6C) (Aittaleb et al., 2010). EhRGS-RhoGEF is unique in possessing a canonical nine-
helix RGS domain, suggesting that the RGS and DH-PH domain combination within E.
histolytica may have arisen through an independent evolutionary mechanism.
In addition to possessing a distinctive RGS domain fold, the mammalian RGS-RhoGEFs
engage Gα12/13 subunits through an effector-like interface, primarily utilizing switch 2 and
the α3 helix on Gα, although the N-terminal extension of the rgRGS domain required for
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GAP activity also contacts the three switches and the all-helical domain (Fig. 7B) (Aittaleb
et al., 2010). In contrast, canonical nine-helix RGS domains primarily interface with Gα
switches 1 and 2 (Fig. 7A) (Soundararajan et al., 2008); hence, the Gα subunit switch 1 Gly-
to-Ser “RGS-insensitivity” mutation selectively disrupts canonical RGS domain interactions
but not Gα/rgRGS domain interactions (Lan et al., 1998; Meigs et al., 2005). To test
whether the EhRGS-RhoGEF RGS domain interfaces with EhGα1 in a canonical fashion,
we generated the EhGα1(G168S) mutant. EhRGS-RhoGEF exhibited drastically lower
affinity for EhGα1(G168S) than wildtype EhGα1, as measured by SPR, and was unable to
affect the intrinsic GTPase rate of EhGα1(G168S) (Fig. 1B, G). These experiments suggest
that the EhGα1/EhRGS-RhoGEF interface most likely resembles a canonical RGS/Gα
interaction, providing further evidence for an independent evolutionary mechanism giving
rise to a Gα/RGS-RhoGEF signaling axis in E. histolytica.
Discussion
The E. histolytica Gα subunit is divergent in its amino acid sequence as compared to
mammalian Gα subunits and, in particular, does not belong to the Gα12/13 subfamily that
couples to mammalian RGS-RhoGEFs (Fig. S6). However, EhGα1 does engage the RGS
domain of EhRGS-RhoGEF in a nucleotide state-dependent fashion, resulting in accelerated
GTP hydrolysis. A search of publicly available sequenced genomes identified the RGS and
DH-PH tandem domain combination exclusively in metazoan species (e.g. C. elegans and D.
melanogaster) with the only non-metazoan exception being the Entamoeba species.
Resistance of EhGα1 to conventional Gα subfamily classification, the RGS4-like nine-helix
RGS domain fold of the EhRGS-RhoGEF N-terminus, and the canonical nature of the
EhGα1/EhRGS-RhoGEF interface, as evidenced by the EhGα1(G168S), EhRGS-
RhoGEF(N83A), and EhRGS-RhoGEF(E39K) mutants, all suggest an evolutionary origin
independent of the Gα12/13/RGS-RhoGEF signaling axis present in mammals.
Mammalian RGS-RhoGEFs are thought to achieve full activation through integration of
multiple signals including, but not limited to, interactions with Gα12/13. For instance, Gα12-
mediated stimulation of leukemia-associated RhoGEF requires tyrosine phosphorylation by
Tec (Suzuki et al., 2003). Consistent with this theme, EhRGS-RhoGEF requires co-
expression, not only with constitutively active EhGα1, but also with constitutively active
EhRacC, to achieve apparent activation as evidenced by S2 cell spreading. Little is currently
known about EhRacC signaling in E. histolytica, although it is evidently a substrate for
EhGEF2 in vitro (Gonzalez De la Rosa et al., 2007). EhRacC was seen to bind EhRGS-
RhoGEF directly, exclusively in the GTP-bound conformation, suggesting that EhRGS-
RhoGEF may serve as an EhRacC effector. Activated human RhoA GTPase has been
demonstrated to bind the PH domain of PDZ-RhoGEF in an analogous fashion (Chen et al.,
2010b). RhoA also serves as a substrate for PDZ-RhoGEF-mediated exchange, suggesting a
possible mode of feedback regulation in mammals. However, there is currently no evidence
that EhRacC is a substrate for EhRGS-RhoGEF; in fact, EDTA-treated, nucleotide-free
EhRacC did not bind appreciably to EhRGS-RhoGEF (Fig. 2D). However, the full-length
isolated EhRGS-RhoGEF used in these experiments is expected to have an obstructed Rho
substrate-binding site, and activation by EhGα1·GTP, EhRacC·GTP, and/or other factors
may be required to allow efficient substrate binding. Although the putative exchange factor
activity of EhRGS-RhoGEF was not directly measureable, selective knockdown of
endogenous D.m. Rac1/2 in S2 cells impaired the cell spreading triggered by co-expression
of EhRGS-RhoGEF, EhGα1(Q/L), and EhRacC(Q/L), suggesting that Drosophila Rac may
serve as a substrate for EhRGS-RhoGEF in a cellular context. However, the cell spreading
experiments provide limited insight into the precise signaling mechanics. For instance,
additional cellular factors may contribute to EhRGS-RhoGEF activation, and we cannot rule
Bosch et al. Page 7










out the possibility that overexpressed E. histolytica signaling components promote cell
spreading through other endogenous signaling pathways.
In isolation, EhRGS-RhoGEF appears to adopt an autoinhibited conformation, with direct
obstruction of the presumptive Rho substrate-binding surface by a putative inhibitory helix
and its DH and PH domain interactions. We hypothesize that binding of EhGα1·GTP and
EhRacC·GTP to EhRGS-RhoGEF, possibly together with other cellular context factors such
as membrane localization or post-translational modifications, may lead to a structural
rearrangement of the putative inhibitory helix and the PH domain, allowing for substrate
Rho GTPase binding and nucleotide exchange. The predicted mode of EhRGS-RhoGEF
autoinhibition, as derived from the crystal structure, is comparable to that of mammalian
PDZ-RhoGEF, seen in solution studies (Zheng et al., 2009). However, in the case of PDZ-
RhoGEF, an acidic stretch of its rgRGS-DH domain linker interacts with a DH domain
surface basic cluster, distinct from the inhibitory helix interface seen here in the crystal
structure of EhRGS-RhoGEF. The rgRGS-DH linker of p115 RhoGEF also apparently
inhibits the GEF activity of its DH-PH domain tandem, although both SAXS analyses and
crystallographic studies of the DH-PH domains with short segments of the linker intact
suggest a different linker disposition than that seen in EhRGS-RhoGEF (Chen et al., 2011).
The RGS-DH linker in EhRGS-RhoGEF is >100 residues shorter than those of mammalian
homologs (Fig. S1C), further suggesting that this region does not have a conserved structure
across species.
Endogenous EhRGS-RhoGEF likely represents a functional signaling link between
heterotrimeric G-proteins and Rho family GTPases in E. histolytica. Indeed, Rho GTPases
and other Dbl family RhoGEFs in E. histolytica are also known to regulate multiple
processes important for pathogenesis such as actin reorganization during chemotaxis,
surface receptor capping, cell killing, phagocytosis, and tissue destruction (Guillen, 1996). A
surprisingly large family of Rho GTPases (>20 members) is apparently simultaneously
expressed in the single-celled parasite (Bosch et al., 2011). Further studies are needed to
determine which Rho family members are activated by EhRGS-RhoGEF and what
downstream signaling pathways are utilized.
Overexpression of EhRGS-RhoGEF resulted in reduced E. histolytica trophozoite
chemotactic migration, attachment to and killing of host cells, and secretion of cysteine
proteases. By each of these measures, the EhRGS-RhoGEF trophozoite strain phenocopies a
strain overexpressing a dominant negative EhGα1 point mutant and exhibits an opposing
trend to trophozoites overexpressing wild type EhGα1 (manuscript in press), consistent with
ectopically overexpressed EhRGS-RhoGEF serving to accelerate GTP hydrolysis on EhGα1
and thus inhibit its signaling. Given the amenability of heterotrimeric G-protein signaling to
pharmacological manipulation (Gilchrist, 2007), this pathway provides a promising drug
target for the treatment of amoebic colitis.
Experimental Procedures
Cloning and protein purification
See Supplemental Experimental Procedures.
Crystallization and structure determination
Crystals of the full-length EhRGS-RhoGEF (a.a. 1-519) yielded diffraction data not suitable
for either molecular replacement or anomalous dispersion. However, by removing two
residues on both the N- and C-termini of EhRGS-RhoGEF we obtained another crystal form
with improved diffraction quality, ultimately allowing structure determination by SAD.
Crystallization was achieved by hanging drop vapor diffusion at 18°C. EhRGS-RhoGEF at
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15 mg/mL in crystallization buffer (50 mM HEPES pH 7.5, 100 mM NaCl, and 1 mM DTT)
was mixed 1:1 and equilibrated against crystallization solution containing 16% (w/v) PEG
3350 and 100 mM sodium malonate pH 5.0. Hexagonal plate crystals grew to 400 × 150 ×
20 μm over 5 days. EhRGS-RhoGEF crystals displayed the symmetry of space group C2 (a
= 86.1 Å, b = 46.3 Å, c = 142.6 Å, α = γ = 90°, β = 104.2°), with one monomer in the
asymmetric unit. Prior to data collection, crystals were cryoprotected in crystallization
solution supplemented with 25% (v/v) glycerol.
Anomalous diffraction data were obtained at 0.97954 Å wavelength (selenium absorption
peak) and 100K temperature at the GM/CA-CAT ID-D beamline (APS, Argonne National
Labs) and processed using HKL2000 (Otwinowski, 1997). A highly redundant data set was
obtained combining partial data sets from five points along the EhRGS-RhoGEF plate
crystal. Heavy atom searching identified 8 of 8 possible sites, and refinement yielded an
estimated Bayes correlation coefficient of 48.2 to 2.5 Å resolution. After density
modification, the estimated Bayes correlation coefficient increased to 66.0. ~75% of the
model was constructed automatically, and the remaining portion was built manually. The
current model (Table 1) contains one EhRGS-RhoGEF monomer.
Refinement was carried out against peak anomalous data with Bijvoet pairs kept separate
using phenix.refine (Adams et al., 2010) interspersed with manual model revisions using the
program Coot (Emsley and Cowtan, 2004) and consisted of conjugate-gradient minimization
and calculation of individual atomic displacement and translation/libration/screw (TLS)
parameters (Painter and Merritt, 2006). Residues that could not be identified in the electron
density were: 1, 139-140, 153-156, and 452-454. The model exhibits excellent geometry as
determined by MolProbity (Chen et al., 2010a). A Ramachandran analysis identified 97.6%
favored, 2.4% allowed, and 0% disallowed residues. Coordinates and structure factors are
deposited in the RCSB Protein Data Bank (id 4GOU).
Single turnover nucleotide hydrolysis
GTP hydrolysis by single turnover assays was quantified as previously described (Bosch et
al., 2010). For GTPase acceleration assays, increasing concentrations of purified EhRGS-
RhoGEF were added along with the hydrolysis-initiating magnesium.
Surface Plasmon Resonance
Optical detection of protein binding was conducted as described previously (Kimple et al.,
2010). Briefly, His6-tagged wild type or mutant EhRGS-RhoGEF was immobilized on an
NTA chip surface by capture coupling and increasing concentrations of wildtype EhGα1
and mutants were flowed over at 10 μL/s in various nucleotide states. In complementary
experiments, GST-EhGα1 was immobilized on an anti-GST chip surface, as described
(Hutsell et al., 2010), and increasing concentrations of EhRGS-RhoGEF and mutants flowed
over.
NTA affinity co-preciptiation
See Supplemental Experimental Procedures.
Trophozoite stable transfection
See Supplemental Experimental Procedures.
Chemotactic migration
Trophozoite migration assays were performed essentially as described previously (Gilchrist
et al., 2008). Briefly, amoebae harvested in log growth phase were suspended in serum free
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TYI growth medium, and 50,000 cells loaded in the upper chamber of a Transwell migration
chamber (Costar, 8 μm pore size). The lower chamber contained growth medium with or
without 15% adult bovine serum. Transwell plates were incubated at 37°C for 2 hr under
anaerobic conditions (GasPak EZ, BD Biosciences).
Host cell attachment
Attachment of E. histolytica trophozoites to epithelial monolayers was assessed as
previously described (Shrimal et al., 2010). Chinese hamster ovary (CHO) cells were grown
to confluency in 24-well plates, washed, and fixed in 4% paraformaldehyde for 30 minutes.
Trophozoites (3 × 105) were added to the fixed monolayers in medium 199 supplemented
with 5.7 mM cysteine, 1 mM ascorbic acid, and 25 mM HEPES (pH 6.9). After incubation
at 37°C for 30 minutes, each well was washed gently two times with warm PBS to remove
unattached trophozoites. Monolayer-attached trophozoites were quantified by counting with
an inverted microscope. Each experiment was performed in quadruplicate and statistical
significance determined by Student’s t-test.
Cell killing
Killing of mammalian cells (Jurkat) was assessed using the CytoTox-ONE membrane
integrity assay (Promega). In 96-well plates, 5 × 105 Jurkat cells and/or 2.5 × 105
trophozoites were incubated at 37°C in 200 μL of medium 199 (Sigma) supplemented with
5.7 mM cysteine, 0.5% BSA, and 25 mM HEPES pH 6.8. After 2 hr, 50 μL of medium from
each well was incubated with Cytotox reagent and a colorimetric measure of extracellular
lactate dehydrogenase activity was obtained after 10 min. Each experiment was performed
in quadruplicate and statistical significance determined by Student’s t-test.
Cysteine protease activity
See Supplemental Experimental Procedures.
S2 cell culture and spreading assay
S2 cells were obtained from the Drosophila Genome Resource Center (Bloomington, IL),
and cultivated as described previously (Rogers and Rogers, 2008). S2 cells were maintained
in SF900 SFM (Invitrogen, Carsbad, CA) and transfected with 2 μg total DNA using the
Amaxa nucleofector system (Lonza, Basel, Switzerland). Expression of transfected
constructs was induced with 35 μM CuSO4. Double stranded RNAs (see Supplemental
Experiment Procedures for primers) were produced using Promega (Madison, WI) Ribomax
T7 kit according to manufacturer instructions. S2 cells at 50-90% confluency in 6-well
plates were treated every other day for 7 days with 7.5 μg/ml of dsRNA. On day 5 of RNAi
treatment, cells were transfected as above and then induced on day 6. Cells were
resuspended and plated on poly-L-lysine (Sigma-Aldrich, St. Louis, MO) coated coverslips
and allowed to spread for 1 hour. For quantifying numbers of cells with spreading, each
condition was repeated at least three times and ≥100 cells were counted per experiment.
Immunofluorescence microscopy
See Supplemental Experimental Procedures.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• E. histolytica expresses a convergently evolved RGS-RhoGEF protein.
• EhRGS-RhoGEF possesses a conventional nine-helix RGS domain.
• Activated EhRGS-RhoGEF induces S2 cell spreading through Rac1/2.
• EhRGS-RhoGEF modulates amoebic migration and host cell killing.
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Figure 1. EhRGS-RhoGEF is an EhGα1 effector that accelerates its GTP hydrolysis
(A-D) Either EhGα1 or EhRGS-RhoGEF was immobilized on a surface plasmon resonance
chip, and the complementary protein flowed over at increasing concentrations. EhRGS-
RhoGEF bound EhGα1 selectively in the GDP·AlF4−-bound state (AMF); interaction
affinity was independent of immobilized species (KD = 5.2 ± 0.8 μM, panel B; 5.7 ± 1.6
μM, panel D). The GTPase-deficient mutant mutant EhGα1(Q189L) also interacted with
EhRGS-RhoGEF, but with lower affinity (KD ≈ 110 μM). Mutation of the conserved
EhRGS-RhoGEF Asn-83, predicted to orient EhGα1 residues for rapid GTP hydrolysis, the
predicted EhGα1-binding surface charge reversal EhRGS-RhoGEF(E39K), and the switch 1
mutant EhGα1(G168S) all drastically reduced binding affinity. Sensorgrams and
equilibrium binding curves are representative of three experiments. (E, F) The GTPase rate
of EhGα1 was accelerated by EhRGS-RhoGEF in a dose-dependent fashion (kobs = 0.20 ±
0.02 min−1 for EhGα1 alone and 1.45 ± 0.13 min−1 upon addition of 25 μM EhRGS-
RhoGEF). EhRGS-RhoGEF(E39K) and EhRGS-RhoGEF(N83A) had no effect on the
hydrolysis rate. (G) GTP hydrolysis rates for the “RGS-insensitivity” mutant
EhGα1(G168S) alone or in the presence of a high concentration of EhRGS-RhoGEF were
indistinguishable. Error bars represent standard error of the mean for duplicate reactions.
Each single turnover hydrolysis experiment was independently repeated at least twice.
Supporting Figures S2 indicates proper folding of the EhRGS-RhoGEF(E39K) mutant and
nucleotide state-specific binding of EhGα1 to the isolated RGS domain.
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Figure 2. EhRGS-RhoGEF activation by constitutively active EhGα1 and EhRacC leads to Rac-
dependent S2 cell spreading
(A-C) Rho family GTPase activation in D. melanogaster S2 cells leads to spreading on a
poly-lysine coated surface (Rogers and Rogers, 2008). Coexpression of EhRGS-RhoGEF
with GTPase-deficient and constitutively active EhGα1(Q189L) was insufficient to effect
cell spreading. However expression of the constitutively active EhRacC(Q65L), together
with EhGα1(Q189L) and EhRGS-RhoGEF significantly enhanced cell spreading, while
EhRacC(Q65L) alone or in combination with EhGα1 had no effect. To determine which D.
melanogaster Rho family GTPases were necessary for cell spreading, and thus potential
substrates for overexpressed EhRGS-RhoGEF, double-stranded RNAi was employed as
described previously (Rogers et al., 2003). RNAi-mediated knockdown of D.m. Rac
isoforms, but not Rho or mtl, prevented significant enhancement of cell spreading by
coexpression of EhRGS-RhoGEF, EhRacC(Q65L), and EhGα1(Q189L). Error bars
represent standard deviation for three independent experiments, and * indicates statistically
significant difference (p < 0.05) by Student’s t-test. Example micrographs are shown in
panel B and western blots confirming expression of all E. histolytica proteins and mutants
are shown in panel C. (D) Recombinant, activated EhRacC(Q65L)·GTP was seen to directly
bind EhRGS-RhoGEF by surface plasmon resonance, while EhRacC·GDP and nucleotide-
free EhRacC exhibited negligible binding up to 40 μM concentration. Supporting Figure S1
contains sequence alignments of EhRGS-RhoGEF and mammalian homologs.
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Figure 3. EhRGS-RhoGEF expression inhibits host cell attachment and killing, cysteine protease
secretion, and chemotactic migration by E. histolytica trophozoites
(A) Amoebae were stably transfected to overexpress EhRGS-RhoGEF (inset). Expression of
EhRGS-RhoGEF reduced the ability of E. histolytica to kill Jurkat (human lymphocyte-
derived) cells compared to the HM-1:IMSS virulent parent strain, as determined by a
membrane integrity assay. (B) Trophozoites expressing EhRGS-RhoGEF exhibited reduced
cysteine protease secretion, a process necessary for host cell killing and extracellular matrix
invasion. (C) Overexpression of RGS-RhoGEF reduced trophzoite chemotactic migration
across a porous membrane toward serum-containing nutritive media, but had no
measureable effect on random migration. (D) Trophozoites attach to CHO cell monolayers,
primarily through a galactose-inhibitable lectin. Overexpression of EhRGS-RhoGEF
reduced lectin-dependent monolayer attachment. All trophozoite experiments were
conducted in quadruplicate. * indicates a statistically significant difference by Student’s t-
test (p < 0.05). Supporting Table S1 indicates transcriptional regulation of EhRGS-RhoGEF
in amoebae overexpressing EhGα1 and mutants.
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Figure 4. The structure of EhRGS-RhoGEF reveals inter-relationship between RGS and DH/PH
domains
(A) The RGS domain (yellow) adopts a canonical 9-helix fold and interacts with the DH
domain (green) opposite from the predicted Rho binding site. The linker between the RGS
and DH domains wraps ~180° around the DH domain and contains a 15-residue α helix
(termed the ‘inhibitory helix’; red) that engages both the conserved PH domain fold (orange)
and the C-terminal portion of the DH domain. (B) The inhibitory helix, DH, and PH
domains are superimposed with the structure of Intersectin/Cdc42 (gray; PDB id 1KI1). The
conserved site of Rho GTPase interaction, illustrated by a surface rendering of Cdc42, is
obstructed in the case of EhRGS-RhoGEF. The inhibitory helix lies entirely within the space
corresponding to Cdc42. In addition, the long α6 helix is continuous in Intersectin and other
RhoGEFs, but is segmented into two helices related by an ~90° angle in EhRGS-RhoGEF.
The α6b helix both interacts with the putative inhibitory helix and contributes to obstruction
of the Rho binding site. The EhRGS-RhoGEF PH domain is also predicted to interfere with
Rho binding in this inactive conformation. Supporting Figure S3 contains an analysis of the
PH domain and its DH domain interface.
Bosch et al. Page 18










Figure 5. The EhRGS-RhoGEF inhibitory helix engages both the DH and PH domains
(A,B) The EhRGS-RhoGEF DH and PH domains share an interface with the hydrophobic
inhibitory helix residues Leu-164, Ile-167, Ile-168, Trp-175, and the aromatic ring of
Tyr-160 (gray sticks). Hydrogen-bond interactions and peripheral ionic interactions, e.g.
Lys-172·Asp-383 and Lys-161·Glu-511, also contribute to this interface. N and C indicate
the N- and C-terminal ends of the inhibitory helix, respectively. A 2Fo-Fc electron density
map of the inhibitory helix is shown in the supporting Figure S4.
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Figure 6. The EhRGS-RhoGEF RGS domain adopts a canonical fold and interacts with the DH
domain
(A) Residues participating in the RGS (yellow) and DH (green) domain interface in EhRGS-
RhoGEF are shown in sticks. A central hydrophobic region is surrounded by polar and ionic
side chain interactions. A 2Fo-Fc electron density map of the RGS/DH interface is shown in
Figure S4B. (B) The EhRGS-RhoGEF RGS domain adopts a 9-helical bundle fold very
similar to canonical RGS domains, typified by RGS4 (red; PDB id 1AGR). (C) In contrast,
the mammalian RGS-RhoGEFs possess an RGS-like domain with 12 helices, as seen in
p115 RGS-RhoGEF (PDB id 1IAP). Dotted lines indicate loops that could not be accurately
modeled. Supporting Figure S5 illustrates crystal contacts of the RGS domain and inhibitory
helix.
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Figure 7. Evolutionary analysis of the EhGα1/EhRGS-RhoGEF signaling pathway
Canonical RGS domains, illustrated by RGS4 (PDB id 1AGR), and rgRGS domains of
mammalian RGS-RhoGEFs, represented by that of p115 (PDB id 3AB3), exhibit distinct
folds. (A) The EhRGS-RhoGEF RGS domain structure (yellow) closely resembles RGS4
(red), suggesting a canonical Gα/RGS domain interaction as exhibited by the RGS4/Gαi1
complex. Canonical RGS domains engage primarily switches 1 and 2, while rgRGS domains
interact with the effector interface of Gα12/13 (orange) family members, primarily through
switch 2 and the α3 helix, although the N-terminal extension required for GAP activity also
contacts the three switch regions and the all-helical domain (B). The EhGα1(G168S),
EhRGS-RhoGEF(E39K), and EhRGS-RhoGEF(N83A) mutations can distinguish between
the two modes of binding by selectively disrupting the canonical RGS domain binding site.
Divergence of EhGα1 sequence from known mammalian subfamilies, together with the
canonical nine-helix RGS domain of EhRGS-RhoGEF and its mode of EhGα1 interaction,
suggest that the EhGα1/RGS-RhoGEF signaling axis arose by an evolutionary mechanism
distinct from and functionally convergent with that of the mammalian Gα12/13/RGS-
RhoGEF axis. Supporting Figure S7 contains a comparison of EhGα1 to mammalian Gα
subfamily members.
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Table 1
Data collection and refinement statistics for selenomethionine EhRGS-RhoGEF.
EhRGS-RhoGEF




 a, b, c (Å) 86.1, 46.3, 142.6
 α, β, γ (°) 90, 104.2, 90
Peak
Wavelength (Å) 0.97954
Resolution (Å) 43.0 - 2.30 (2.32 - 2.30)*
No. unique reflections 46,832
Rmerge (%) 8.9 (58.4)**
I / σl 18.5 (2.0)
Completeness (%) 98.8 (86.4)
Redundancy 4.3 (2.5)
Wilson B-factor (Å2) 25.6
Refinement
Resolution (Å) 43.0 - 2.30 (2.35 - 2.30)
No. reflections 46,587 (2639)










 Bond lengths (Å) 0.008
 Bond angles (°) 1.080
*
Values in parentheses are for highest-resolution shell.
**
All data were collected from a single crystal.
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